Abstract
The newly discovered SEN D and SEN H viruses are transmitted parenterally and can cause post-transfusion hepatitis. We assessed whether coinfection of patients with chronic hepatitis C and SEN D or SEN H correlates with the outcome of treatment with interferon and ribavirin. Of 31 patients with hepatitis C studied, six were positive for SEN D and seven for SEN H (one was positive for both). All of those positive for SEN D and five of those positive for SEN H failed to respond to therapy. Overall response (RNA titre and alanine aminotransferase concentration after treatment) was lower in SEN-infected patients than uninfected patients (p=0.025). We conclude that coinfection with SEN viruses is frequent in chronic hepatitis C patients and might adversely affect the outcome of treatment with interferon and ribavirin.
| Original language | English |
|---|---|
| Pages (from-to) | 1961-1962 |
| Number of pages | 2 |
| Journal | The Lancet |
| Volume | 358 |
| Issue number | 9297 |
| DOIs | |
| State | Published - Dec 8 2001 |
Fingerprint
Dive into the research topics of 'Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver